Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021

Main Article Content

Sachi A. Patil, MD, MSCI
Daniel G. Vail, MD
Jacob T. Cox, MD, MPhil
Evan M. Chen, MD
Prithvi Mruthyunjaya, MD
James C. Tsai, MD, MBA
Ravi Parikh, MD, MPH


To identify temporal and geographic trends in private equity (PE)–backed acquisitions of ophthalmology and optometry practices in the United States from 2012 to 2021.
In this cross-sectional time series, acquisition data from 10/21/2019 to 9/1/2021 and previously published data from 1/1/2012 to 10/20/2019 were analyzed. Acquisition data were compiled from 6 financial databases, 5 industry news outlets, and publicly available press releases. Linear regression models were used to compare rates of acquisition. Outcomes included number of total acquisitions, practice type, locations, provider details, and geographic footprint.
A total of 245 practices associated with 614 clinical locations and 948 ophthalmologists or optometrists were acquired by 30 PE-backed platform companies between 10/21/2019 and 9/1/2021. Of 30 platform companies, 18 were new vis-à-vis our prior study. Of these acquisitions, 127 were comprehensive practices, 29 were retina practices, and 89 were optometry practices. From 2012 to 2021, monthly acquisitions increased by 0.947 acquisitions per year (P < 0.001*). Texas, Florida, Michigan, and New Jersey were the states with the greatest number of PE acquisitions, with 55, 48, 29, and 28 clinic acquisitions, respectively. Average monthly PE acquisitions were 5.71 per month from 1/1/2019 to 2/29/2020 (pre-COVID), 5.30 per month from 3/1/2020 to 12/31/2020 (COVID pre-vaccine [P = 0.81]), and 8.78 per month from 1/1/2021 to 9/1/2021 (COVID post-vaccine [P = 0.20]).
PE acquisitions increased during the period 2012-2021 as companies continue to utilize regionally focused strategies for acquisitions.


Download data is not yet available.

Article Details

How to Cite
Patil SA, Vail DG, Cox JT, Chen EM, Mruthyunjaya P, Tsai JC, Parikh R. Private equity in ophthalmology and optometry: a time series analysis from 2012 to 2021. Digit J Ophthalmol. 2023;29(1):1-8. doi:10.5693/djo.01.2022.10.004
Original Articles


Nie J, Demkowicz PC, Hsiang W, et al. Urology practice acquisitions by private equity firms from 2011–2021. Urol Prac 2022;9:17-24. DOI:

Gilreath M, Morris S, Brill JV. Physician practice management and private equity: market forces drive change. Clin Gastroenterol Hepatol 2019;17:1924-8.e2. DOI:

Robbins CJ, Rudsenske T, Vaughan JS. Private equity investment in health care services. Health Aff (Millwood) 2008;27:1389-98. DOI:

Tan S, Seiger K, Renehan P, Mostaghimi A. Trends in private equity acquisition of dermatology practices in the United States. JAMA Dermatol 2019;155:1013-21. DOI:

Fleishon HB, Vijayasarathi A, Pyatt R, Schoppe K, Rosenthal SA, Silva E 3rd. White paper: corporatization in radiology. J Am Coll Radiol 2019;16:1364-74. DOI:

Gilreath M, Patel NC, Suh J, Brill JV. Gastroenterology physician practice management and private equity: thriving in uncertain times. Clin Gastroenterol Hepatol 2021;19:1084-87. DOI:

Chen EM, Cox JT, Begaj T, Armstrong GW, Khurana RN, Parikh R. Private equity in ophthalmology and optometry: analysis of acquisitions from 2012 through 2019 in the United States. Ophthalmology 2020;127:445-55. DOI:

Young A. Private equity ensures strong succession, peace of mind for some practices. Ocular Surgery News, 2021. Available at

Patel SN, Groth S, Sternberg Jr. P. The emergence of private equity in ophthalmology. JAMA Ophthalmol 2019;137:601-2. DOI:

Portney DS, Zhu Z, Chen EM, et al. COVID-19 and Use of Teleophthalmology (CUT Group): trends and diagnoses. Ophthalmology 2021;128:1483-5. DOI:

Baum A, Kaboli PJ, Schwartz MD. Reduced in-person and increased telehealth outpatient visits during the COVID-19 pandemic. Ann Intern Med 2021;174:129-31. DOI:

Satiani B, Davis CA. The financial and employment effects of coronavirus disease 2019 on physicians in the United States. J Vasc Surg 2020;72:1856-63. DOI:

Gill D. How low interest rates can hurt competition, and the economy. Chicago Booth Review—economics, 2019. Available at

Lexa FJ, Lexa FJ. Private equity-backed hospital investments and the impact of the coronavirus disease 2019 (COVID-19) epidemic. J Am Coll Radiol 2020;17:1049-52. DOI:

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157-60.

Schmidt H, Weintraub R, Williams MA, et al. Equitable allocation of COVID-19 vaccines in the United States. Nat Med 2021;27:1298-1307. DOI:

O’Donnell EM, Lelli GJ, Bhidya S, Casalino LP. The growth of private equity investment in health care: perspectives from ophthalmology. Health Aff (Millwood) 2020;39:1026-31. DOI:

Gondi S, Song Z. Potential implications of private equity investments in health care delivery. JAMA 2019;321:1047-48. DOI:

Kirsh GM, Kapoor DA. Private equity and urology: an emerging model for independent practice. Urol Clin North Am 2021;48:233-44. DOI:

U.S. Department of Health and Human Services National Center for Health Workforce Analysis. National and regional projections of supply and demand for surgical specialty practitioners: 2013-2025. Available at

American Academy of Ophthalmology. Recommendations for urgent and nonurgent patient care 2020. March 18, 2020. Available at

Wan KH, Lin TPH, Ko CN, Lam DSC. Impact of COVID-19 on ophthalmology and future practice of medicine. Asia Pac J Ophthalmol (Phila) 2020;9:279-80. DOI:

Parke DW 2nd. Ophthalmology after coronavirus disease 2019 (COVID-19): transition back to patient care. JAMA Ophthalmol 2020;138:599-600. DOI:

Bruch JD, Gondi S, Song Z. Changes in hospital income, use, and quality associated with private equity acquisition. JAMA Intern Med 2020;180:1428-35. DOI:

Braun RT, Bond AM, Qian Y, Zhang M, Casalino LP. Private equity in dermatology: effect on price, utilization, and spending. Health Aff (Millwood) 2021;40:727-35. DOI:

Parke DW 2nd. Corporatization in ophthalmology. Ophthalmology 2020;127:456-7. DOI:

Kent C. Is a private equity deal right for you? (Pt 2). Review of Ophthalmology, May 10, 2018. Available at

Chang RK, Joyce JJ, Castillo J, Ceja J, Quan P, Klitzner TS. Parental preference regarding hospitals for children undergoing surgery: a trade-off between travel distance and potential outcome improvement. Can J Cardiol 2004;20:877-82.

Landau JH, Novick TV, Dubois L, et al. Determination of patient preference for location of elective abdominal aortic aneurysm surgery. Vasc Endovascular Surg 2013;47:288-93. DOI:

Finlayson SR, Birkmeyer JD, Tosteson AN, Nease Jr RF. Patient preferences for location of care: implications for regionalization. Med Care 1999;37:204-9. DOI:

Ferry JH, Mehta JP, Puri CC. Congress renews push on investigating private equity investment in healthcare. 2021. Available at